Gabelli Price To Sales Ratio from 2010 to 2024
| GRX Stock | USD 10.42 0.12 1.17% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 120.05008837 | Current Value 126.05 | Quarterly Volatility 54.09186689 |
Check Gabelli Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gabelli Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 734 K or Total Revenue of 1.2 M, as well as many indicators such as Price To Sales Ratio of 126, Dividend Yield of 0.0562 or PTB Ratio of 0.61. Gabelli financial statements analysis is a perfect complement when working with Gabelli Healthcare Valuation or Volatility modules.
Gabelli | Price To Sales Ratio |
Latest Gabelli Healthcare's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Gabelli Healthcare WellnessRx over the last few years. Price to Sales Ratio is figured by comparing Gabelli Healthcare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Gabelli Healthcare sales, a figure that is much harder to manipulate than other Gabelli Healthcare WellnessRx multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Gabelli Healthcare's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gabelli Healthcare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 127.51 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Gabelli Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 12.78 | |
| Geometric Mean | 10.02 | |
| Coefficient Of Variation | 423.37 | |
| Mean Deviation | 29.41 | |
| Median | 5.56 | |
| Standard Deviation | 54.09 | |
| Sample Variance | 2,926 | |
| Range | 239 | |
| R-Value | 0.40 | |
| Mean Square Error | 2,635 | |
| R-Squared | 0.16 | |
| Significance | 0.13 | |
| Slope | 4.89 | |
| Total Sum of Squares | 40,963 |
Gabelli Price To Sales Ratio History
About Gabelli Healthcare Financial Statements
Gabelli Healthcare investors use historical fundamental indicators, such as Gabelli Healthcare's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Gabelli Healthcare. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 120.05 | 126.05 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gabelli Stock Analysis
When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.